These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 26465070)
1. New antibiotic strategies in patients with cirrhosis and bacterial infection. Fernández J; Acevedo J Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070 [TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients. Satlin MJ; Walsh TJ Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897 [TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review. Reddy P; Chadaga S; Noskin GA J Hosp Med; 2009 Jul; 4(6):E8-15. PubMed ID: 19670375 [TBL] [Abstract][Full Text] [Related]
5. The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications. Acevedo J; Silva A; Prado V; Fernández J Hepatol Int; 2013 Mar; 7(1):72-9. PubMed ID: 26201623 [TBL] [Abstract][Full Text] [Related]
6. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey. Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499 [TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V; J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. Piano S; Singh V; Caraceni P; Maiwall R; Alessandria C; Fernandez J; Soares EC; Kim DJ; Kim SE; Marino M; Vorobioff J; Barea RCR; Merli M; Elkrief L; Vargas V; Krag A; Singh SP; Lesmana LA; Toledo C; Marciano S; Verhelst X; Wong F; Intagliata N; Rabinowich L; Colombato L; Kim SG; Gerbes A; Durand F; Roblero JP; Bhamidimarri KR; Boyer TD; Maevskaya M; Fassio E; Kim HS; Hwang JS; Gines P; Gadano A; Sarin SK; Angeli P; Gastroenterology; 2019 Apr; 156(5):1368-1380.e10. PubMed ID: 30552895 [TBL] [Abstract][Full Text] [Related]
11. Changing options for prevention and treatment of infections in cirrhosis. Acevedo J; Prado V; Fernández J Curr Treat Options Gastroenterol; 2014 Jun; 12(2):256-67. PubMed ID: 24705946 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
13. [Multidrug-resistant bacteria and travel]. De Vallière S Rev Med Suisse; 2017 May; 13(561):944-947. PubMed ID: 28627852 [TBL] [Abstract][Full Text] [Related]
14. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review. Fiore M; Maraolo AE; Gentile I; Borgia G; Leone S; Sansone P; Passavanti MB; Aurilio C; Pace MC World J Gastroenterol; 2017 Jul; 23(25):4654-4660. PubMed ID: 28740354 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital. Chaisathaphol T; Chayakulkeeree M J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S35-45. PubMed ID: 24772579 [TBL] [Abstract][Full Text] [Related]
16. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China. Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. Zilberberg MD; Shorr AF J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous bacterial peritonitis due to multidrug resistant bacteria: are the current guidelines outdated? Fiore M Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):731. PubMed ID: 27111388 [No Abstract] [Full Text] [Related]
19. Bacterial infections in hematopoietic stem cell transplantation recipients. Mikulska M; Del Bono V; Viscoli C Curr Opin Hematol; 2014 Nov; 21(6):451-8. PubMed ID: 25295742 [TBL] [Abstract][Full Text] [Related]
20. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review. Allaire M; Cadranel JF; Nguyen TTN; Garioud A; Zougmore H; Heng R; Perignon C; Ollivier-Hourmand I; Dao T Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):264-274. PubMed ID: 31706985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]